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AbstrAct
Introduction Cerebral palsy is the most common cause 
of physical disability in children and adolescents and is 
associated with impairments that may reduce the quality 
of life (QOL) of this population. Patient-reported outcome 
measures (PROMs) can facilitate the assessment of the 
effect of disease and treatment on QOL, from a patient 
viewpoint. The purpose of this systematic review is 
to identify PROMs that are used to measure QOL and 
subjective well-being (SWB) outcomes in young people 
with cerebral palsy and to evaluate the suitability of these 
PROMs for application in economic evaluations within this 
population.
Methods and analysis MEDLINE, Scopus, the Cochrane 
Library, Web of Science Core Collection, EconLit, PsycINFO, 
CINAHL, EMBASE and Informit will be systematically 
searched from inception to date of search. Published 
peer-reviewed, English-language articles reporting 
PROMs measuring QOL or SWB outcomes in children 
and adolescents with cerebral palsy will be included. 
One reviewer will conduct the initial search and screen 
titles and abstracts for potentially eligible studies. The 
search will be performed in November 2017. To reduce 
the likelihood of reviewer selection bias, two other 
reviewers will independently screen a randomly selected 
subsample (10%) of the citations. Two reviewers will 
then retrieve full texts of potentially eligible studies 
and assess them against predefined inclusion criteria. 
The suitability of selected PROMs for use in economic 
evaluations of young people with cerebral palsy will be 
assessed using the International Society of Quality of Life 
Research recommended Minimum Standards and the 
Patient-Centered Outcomes and Comparative Effectiveness 
Research checklist. A narrative synthesis of extracted data 
will be presented including study descriptive data, PROMs 
measurement properties, settings in which they were 
applied and the valuation methods. Recommendations for 
practice on the selection of PROMs for use in economic 
evaluations of children and adolescents with cerebral palsy 
will be presented.
Ethics and dissemination Ethical approval is not 
required as the proposed systematic review will not use 
primary data. The results of this study will be widely 
disseminated through publication in a peer-reviewed 
journal and conference presentation(s).
systematic review registration number International 
Prospective Register of Systematic Reviews number: 
CRD42016049746.
IntroductIon
Patient-reported outcome measures 
(PROMs) are increasingly being used in 
health services research to inform health-
care resource allocation decisions.1 2 PROMs 
assess a patient’s subjective assessment of 
their well-being, health status or quality of 
life (QOL) at a single point in time and are 
collected via standardised, self-report ques-
tionnaires.3 4 PROMs may be differentiated 
into condition-specific and generic measures. 
Condition-specific measures are designed to 
assess health outcomes in people with specific 
medical conditions (eg, the Cerebral Palsy 
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Protocol
strengths and limitations of this study
 ► One of the strengths of this study is that an extensive 
literature search of existing patient-reported 
outcome measures (PROMs) (both preference based 
and non-preference based) that are used to assess 
quality of life  (QOL) in children and young people 
with cerebral palsy will be performed.
 ► Another strength of this systematic review is that 
a comprehensive examination of the suitability of 
preference-based PROMs for use within both trial-
based and model-based economic evaluations of 
paediatric populations with cerebral palsy will be 
performed.
 ► A limitation of this systematic review is the exclusion 
of studies that are not published in English, which 
may mean that some articles examining QOL 
outcomes in young people with cerebral palsy in 
non-English-speaking countries maybe omitted.
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Quality of Life questionnaire); while generic measures 
(eg, the Pediatric Quality of Life Inventory) are applicable 
across all disease areas. Condition-specific and generic 
measures can be subdivided into preference/utility-based 
PROMs and non-preference-based PROMs. Non-pref-
erence-based measures use a simple summative scoring 
system whereby individual items or dimensions are used to 
generate summary scores.5 Preference-based PROMs typi-
cally incorporate scoring algorithms which are premised 
on preferences of general population samples for health 
states generated through valuation methods such as the 
standard gamble) and time trade-off techniques, and 
are usually anchored between 0 (representing death) 
and 1 (representing optimal health). Preference-based 
PROMs enable the calculation of quality-adjusted life 
years (QALYs) for use in cost-utility analysis, a type of 
economic evaluation.5–7 QALYs are a routinely used stan-
dard measure of benefit in economic evaluation.8
Cerebral palsy is a complex chronic disorder of 
motor impairment that requires long-term medical and 
supportive care services. It is the leading cause of phys-
ical disability in childhood with prevalence rates ranging 
between 2.0 and 3.5 per 1000 live births worldwide.9 
There are broad variations in the definition and classi-
fication of cerebral palsy. However, the International 
Executive Committee for the Definition of Cerebral Palsy 
recommend the following definition: ‘Cerebral palsy 
describes a group of permanent disorders of the devel-
opment of movement and posture, causing activity limita-
tion, which are attributed to non-progressive disturbances 
that occurred in the developing fetal or infant brain. 
The motor disorders of cerebral palsy are often accom-
panied by disturbances of sensation, perception, cogni-
tion, communication and behaviour, by epilepsy and by 
secondary musculoskeletal problems’.10 As such, cerebral 
palsy has ubiquitous impacts on all aspects of a child’s life. 
Cerebral palsy has been shown to have a negative effect 
on the QOL of children with the condition.11 12 The cost 
of care for persons with cerebral palsy in Australia was 
estimated at AU$43 431 per person per year in 2007 with 
the total annual national economic cost of cerebral palsy 
estimated at AU$1.47 billion (of which approximately 
37% was borne by the individual and/or their family).13 
In the USA in 2005, the total Medicaid expenditures aver-
aged US$43 338 for a child with cerebral palsy14 and the 
average lifetime cost of cerebral palsy (based on 2003 US 
dollars) was estimated to be US$921 000 per person of 
which 81% are indirect costs and 19% are direct costs.15 
In 2007, a Dutch study on children with cerebral palsy, 
found the annual cost to be €40 265 per child.16 Clearly, 
it is vital to consider the impact of the cost of long-term 
care on young people and/or their families. With these 
rising costs and competing healthcare demands, there is 
a growing need for optimal funding decisions. Economic 
evaluation is an important technique to help deci-
sion makers determine the relative value for money of 
service innovations in healthcare and requires the robust 
measurement of appropriate health, health status, QOL 
or subjective well-being (SWB) outcomes.17 This high-
lights the importance of finding appropriate PROMs for 
economic evaluation of services targeted at children and 
young people with this condition.
The World Health Organisation defines QOL as ‘an 
individual’s perception of their position in life in the 
context of the culture and value system in which they 
live, and in relation to their goals, expectations, stan-
dards and concern’.18 QOL is a broad concept which 
refers to the influence of all facets of an individual’s life 
on their general well-being including health-related QOL 
(HRQOL). HRQOL refers to an individual’s self-per-
ceived assessment of their health and its subsequent 
effect on their life and is defined as a subjective multidi-
mensional construct of well-being and functioning based 
on physical, emotional, mental, social and behavioural 
features as perceived by patients.19 In literature these two 
concepts, QOL and HRQOL are used interchangeably,20 
for the purposes of this systematic review both terms will 
be considered in the search strategy.
The main aim of this systematic review is to identify 
studies that have used PROMs to assess QOL and SWB in 
children with cerebral palsy and to evaluate the suitability 
of these PROMs for application in economic evaluations 
targeted at this population. Previous systematic reviews 
in cerebral palsy have focused on assessing performance 
of psychometric-based physical activity and/or participa-
tion measures21 22 and QOL.23–25 These reviews did not 
distinguish between measures associated with different 
cerebral palsy health states depicting the levels of severity 
as classified using a number of metrics including gross 
motor function26 manual ability27 and communication.28 
Further, only Janssens et al25 included preference-based 
outcome measures in their review even though the popu-
lation was that of children and young people living with 
neurological disabilities and not exclusive to those with 
cerebral palsy. This current review may be distinguished 
from previous ones in three main ways:
First, this review is focused exclusively on cerebral palsy. 
Second, the review will assess the appropriateness of 
the PROMs applied for informing QOL associated with 
different cerebral palsy health states for the purposes of 
model-based economic evaluation. Third, information on 
the contexts in which the PROMs have been used will also 
be extracted and collated so as to determine the suitability 
of particular PROMs for particular settings (with context 
defined according to the functional ability of populations 
as measured by the Gross Motor Function Classification 
System,26 in which the instruments have been used).
The specific objectives of the review are:
 ► To identify PROMs that are used to measure QOL and 
SWB outcomes in children and young people aged 
0–18 years with cerebral palsy.
 ► To establish the different contexts in which the 
PROMs have been applied.
 ► To critically examine the suitability of prefer-
ence-based PROMs for use within economic evalua-
tions targeted at this population.
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review questions
The proposed review will seek to address the following 
specific research questions:
 ► What preference-based PROMs and non-prefer-
ence-based PROMs are used to measure QOL and 
SWB outcomes in children and young people with 
cerebral palsy?
 ► How suitable are the identified PROMs for use within 
economic evaluations of paediatric populations with 
cerebral palsy and in what contexts?
MEthods
design
This protocol has been registered with the International 
Prospective Register of Systematic Reviews (PROSPERO) 
(registration number CRD42016049746) and it has 
been developed using the Preferred Reporting Items for 
Systematic Review and Meta-Analysis Protocols (PRIS-
MA-P) checklist.29 The review will be conducted in accor-
dance with the PRISMA statement.30
The systematic review will follow a structured two-stage 
approach. First, all PROMs (both preference-based and 
non-preference-based) and articles/studies reporting 
details of development and/or application of PROMs 
used to measure QOL and/or SWB in young people 
with cerebral palsy will be identified. Second, each 
of the PROMs identified will be appraised using two 
checklists: The International Society of Quality of Life 
Research (ISOQOL) recommended Minimum Stan-
dards for Patient-Reported Outcome Measures,31 and the 
Patient-Centered Outcomes and Comparative Effective-
ness Research (CREATE) checklist for reporting valua-
tion studies.32 The ISOQOL was included for purposes 
of appraising non-preference-based and CREATE will 
be used to appraise the candidate utility-based (prefer-
ence-based) PROMs. A University of South Australia 
Health Sciences Librarian with expertise in designing 
systematic reviews will be available to the team and 
will provide guidance on the search strategies for each 
database.
Eligibility criteria
Published, peer-reviewed, English-language articles 
reporting QOL and SWB outcomes of children and 
young people aged 0–18 years with a diagnosis of cerebral 
palsy will be eligible for inclusion in the initial stage of the 
systematic review.
There is currently no consensus regarding the inclu-
sion or exclusion of non-English-language articles to 
systematic reviews. Some authors seem to suggest that 
excluding non-English-language studies from system-
atic reviews may lead to language-bias and subsequently 
lead to inaccurate conclusions. However, other studies 
have reported results contrary to this which suggest that 
restricting searches to the English language does not alter 
the outcome of systematic reviews and meta-analyses.33 34 
This is more so true in clinical fields which have a high 
prevalence of English-language articles and research.
Inclusion criteria
 ► The review will include all study designs in the prelim-
inary search because it is expected that the number 
of preference-based PROMs in this field is relatively 
small.
 ► There will be no restrictions in terms of setting for 
the initial search because the literature in this field 
is likely to be relatively small and any restrictions at 
this stage over and above ‘care-related’ (rather than 
generic) would hinder any wider recommendations.
 ► To allow for a relatively broader definition of carers 
beyond primary carers, studies where PROMs were 
completed by either the child, parent (primary 
caregiver), clinician, teachers or school principal, 
among others will be included.
 ►  Both preference and non-preference instruments will 
be included as well as generic and condition-specific 
instruments.
Exclusion criteria
 ► Studies focused only on adults. Studies that examine 
participants across both child/adolescent and adult 
age ranges will only be included if majority of the 
sample are children/adolescent and 0–18 years and if 
results are for the two categories reported separately.
 ► Studies where QOL and SWB data are on parents and 
caregivers of children with cerebral palsy.
 ► Publications that are not peer-reviewed including 
unpublished dissertations, reports, conference pres-
entations, discussion papers and any grey literature. 
This is so as to ensure that only articles that have gone 
through the rigorous review and editorial process are 
included.
search strategy
An extensive search of the literature will be conducted 
in nine electronic bibliographic databases from database 
inception to the date of the search: MEDLINE (including 
in-process and other non-indexed citations via Ovid 
interface); Scopus (via Elsevier interface); The Cochrane 
Library (including the Cochrane CENTRAL, EED and 
HTA); Web of Science Core Collection; EconLit (via Ovid 
interface); EMBASE (via Ovid interface); PsycINFO (via 
Ovid interface); CINAHL (via EBSCO-host); Informit 
(via Informit interface). The primary electronic search 
strategy was designed for MEDLINE and adapted as 
appropriate for each of the databases. The full search 
strategy is presented in the online supplementary 
appendix. Keywords and Medical Subject Headings terms 
include: ‘cerebral palsy’, ‘children’, ‘adolescents’, ‘quality 
of life’, ‘health related quality of life’ and ‘well-being’. 
To ensure that all significant literature is retrieved, both 
forward (inspecting articles in order to determine if key 
articles have been cited) and backward (examining refer-
ence lists) citation checking will be performed on all full 
texts examined so as to ensure that no eligible studies are 
missed out. Results from the search and retrieved refer-
ences will be imported and managed in Thomson Reuters 
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Endnote V.X7.1 (2014) reference management software. 
The search will be performed in November 2017.
selection process
First, all titles and abstracts of articles resulting from the 
search will be screened against the eligibility criteria inde-
pendently by the lead review author (CM), as has been 
done elsewhere.35–37 The primary aim of screening is to 
identify articles that meet the inclusion criteria. Full texts 
will be retrieved at this initial stage only if the abstract 
contains limited information about the study.All duplicate 
articles will be removed. To reduce the possibility of selec-
tion bias, a randomly selected subset of citations (20%) 
will be independently assessed by two other members of 
the review team (GC and EH).37 Cohen’s Kappa statistic 
will be estimated to measure inter-rater reliability (degree 
of agreement) between the reviewers.38–40 Cohen’s Kappa 
statistic values less than or equal to 0 indicate no agree-
ment, 0.01–0.20 (none to slight), 0.21–0.40 (fair), 0.41–
0.60 (moderate), 0.61–0.80 (substantial) and 0.81–1.00 
(strong) agreement. If the inter-rater reliability is less than 
0.80, that is, strong level of agreement,39 an additional 
subset of articles (25%) will be independently assessed. 
If the degree of agreement between the review authors 
is still less than 0.80, then the rest of the articles will be 
independently screened. Differences will be resolved by 
discussion and consultation with the review team. Second, 
full texts of potential candidate studies will be obtained 
and assessed for inclusion in the review. To ensure that all 
relevant literature is retrieved, both forward (inspecting 
in order to determine if key articles have been cited) and 
backward (examining reference lists) citation chasing 
will be performed. Where necessary, study authors will be 
contacted for clarification and additional information to 
inform study selection. Each stage of the selection process 
will be outlined in a PRISMA-style flow chart and assessed 
against the 27-item PRISMA checklist.
data collection
Summary data of each included PROM and article will 
be extracted into a data extraction form specifically 
designed for this review. Summary tables will be created 
in Microsoft Office Excel 2013 for (1) information about 
the candidate PROMs and (2) information pertaining to 
the identified studies. The information to be extracted 
from the included studies will be the following:
 ► Descriptive information about study: date of publi-
cation; country of origin; sample size; study type 
and setting; study population and characteristics 
(including age, gender and Gross Motor Func-
tioning Classification System); study key results and 
conclusions.
 ► Descriptive information about the measure: name 
of PROM; domains/dimensions; number of items; 
description of the items; response method; method of 
administration; interpretation and summary scoring.
 ► Information about valuation of measure, that is, 
have preference weights been collected from a 
representative sample of children and adolescents 
with cerebral palsy? health states valued; preference 
elicitation method; population preference weights.
Two other reviewers will independently appraise the 
quality and suitability of the preference-based PROMs 
for measuring outcomes in paediatric populations with 
cerebral palsy. Any disagreements will be resolved by 
discussion and consultation with the review team. This 
evaluation will also follow the ISOQOL checklist (for 
internal consistency reliability, test–retest reliability, 
content validity, construct validity, criterion validity, 
responsiveness, interpretability of scores, respondent 
burden and investigator burden)31 and the CREATE 
checklist (for reporting valuation studies) to appraise the 
candidate utility-based PROMs.32
data synthesis
A summary of included studies and PROMs will be 
presented in line with recommendations from the 
Cochrane Collaboration.41 The main features of the 
included studies, instrument descriptions and contexts in 
which they are applied and information about valuation 
methods will be summarised into three tables.42 Using 
this information, the suitability of each of the PROMs 
identified for use in economic evaluation will be assessed 
and comparisons and disparities between instruments will 
be described.
dIscussIon
To the best of our knowledge, this is the first systematic 
review that will comprehensively assess existing PROMs 
(both preference-based and non-preference-based) that 
are used to measure QOL in children and young people 
with cerebral palsy. Multiple bibliographic databases 
will be systematically searched from inception to date 
of search. This review will advance the field of health 
economics research in the following ways: first, the review 
will identify PROMs used to measure QOL and SWB 
in young people with cerebral palsy aged 0–18 years. 
Second, the review will establish the different contexts in 
which the PROMs have been applied. Third, the system-
atic review will provide evidence on the suitability of pref-
erence-based PROMs for use within both trial-based and 
model-based economic evaluations of paediatric popula-
tions with cerebral palsy.
A limitation of this systematic review is the exclusion 
of studies that are not published in English, which may 
mean that some articles examining QOL outcomes 
in young people with cerebral palsy in non-En-
glish-speaking countries maybe omitted. However based 
on results of previous reviews22 24 25 in this field as well 
as expertise and research experience of the research 
team, we do not anticipate a large number of non-En-
glish articles in this field and are therefore confident 
that no significant difference will be made by excluding 
them.
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EthIcs And dIssEMInAtIon
The main aim of this review is to provide a systematic 
review of existing published literature and as such ethical 
approval to conduct this research is not required. This 
systematic review is registered with the PROSPERO 
(http://www. crd. york. ac. uk/ PROSPERO/ display_ 
record. asp? ID= CRD42016049746),43 registration number 
CRD42016049746. The findings of this review will be 
disseminated as a peer-reviewed journal article and will be 
presented at both national and international conferences.
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